Daugaard et al. [17] reported elevated LEDGF/p75 transcript expression in human breast and bladder cancers, and that its ectopic overexpression in breast cancer cells protected against drug-induced lysosomal cell death and increased the tumorigenic potential of the cancer cells in murine models. This evidence concerns the gene PSIP1 and urinary bladder carcinoma.